Drug · DIN 02485605
CYSTADROPS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 15, 2019; first marketed May 15, 2019.
- Drug Identification Number (DIN)
- 02485605
- Company (DIN owner)
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Mercaptamine S01XA21
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CYSTEAMINE (CYSTEAMINE HYDROCHLORIDE) | 0.37 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 11, 2019: NOC 21855New Drug Submission (NDS)